• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 与多器官衰竭:潜在机制的叙述性综述。

COVID-19 and multiorgan failure: A narrative review on potential mechanisms.

机构信息

CAS Key Laboratory of Mental Health, Institute of Psychology, Beijing, China.

Department of Psychology, University of Chinese Academy of Sciences, Beijing, China.

出版信息

J Mol Histol. 2020 Dec;51(6):613-628. doi: 10.1007/s10735-020-09915-3. Epub 2020 Oct 4.

DOI:10.1007/s10735-020-09915-3
PMID:33011887
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7533045/
Abstract

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in December 2019 form Wuhan, China leads to coronavirus disease 2019 (COVID-19) pandemic. While the common cold symptoms are observed in mild cases, COVID-19 is accompanied by multiorgan failure in severe patients. The involvement of different organs in severe patients results in lengthening the hospitalization duration and increasing the mortality rate. In this review, we aimed to investigate the involvement of different organs in COVID-19 patients, particularly in severe cases. Also, we tried to define the potential underlying mechanisms of SARS-CoV2 induced multiorgan failure. The multi-organ dysfunction is characterized by acute lung failure, acute liver failure, acute kidney injury, cardiovascular disease, and as well as a wide spectrum of hematological abnormalities and neurological disorders. The most important mechanisms are related to the direct and indirect pathogenic features of SARS-CoV2. Although the presence of angiotensin-converting enzyme 2, a receptor of SARS-CoV2 in the lung, heart, kidney, testis, liver, lymphocytes, and nervous system was confirmed, there are controversial findings to about the observation of SARS-CoV2 RNA in these organs. Moreover, the organ failure may be induced by the cytokine storm, a result of increased levels of inflammatory mediators, endothelial dysfunction, coagulation abnormalities, and infiltration of inflammatory cells into the organs. Therefore, further investigations are needed to detect the exact mechanisms of pathogenesis. Since the involvement of several organs in COVID-19 patients is important for clinicians, increasing their knowledge may help to improve the outcomes and decrease the rate of mortality and morbidity.

摘要

2019 年 12 月,严重急性呼吸综合征冠状病毒 2(SARS-CoV2)在中国武汉爆发,导致 2019 年冠状病毒病(COVID-19)大流行。虽然轻症患者表现出普通感冒症状,但 COVID-19 会导致重症患者多器官衰竭。重症患者不同器官受累导致住院时间延长,死亡率增加。在这篇综述中,我们旨在研究 COVID-19 患者,尤其是重症患者的不同器官受累情况。同时,我们试图确定 SARS-CoV2 引起多器官衰竭的潜在潜在机制。多器官功能障碍的特征是急性呼吸衰竭、急性肝功能衰竭、急性肾损伤、心血管疾病以及广泛的血液异常和神经系统疾病。最重要的机制与 SARS-CoV2 的直接和间接致病特征有关。虽然已经证实 SARS-CoV2 的肺、心脏、肾脏、睾丸、肝脏、淋巴细胞和神经系统中存在血管紧张素转换酶 2(SARS-CoV2 的受体),但关于这些器官中是否存在 SARS-CoV2 RNA 的观察结果存在争议。此外,器官衰竭可能是由细胞因子风暴引起的,这是炎症介质水平升高、内皮功能障碍、凝血异常和炎症细胞浸润到器官的结果。因此,需要进一步研究以检测发病机制的确切机制。由于 COVID-19 患者涉及多个器官,这对临床医生很重要,增加他们的知识可能有助于改善结果并降低死亡率和发病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac9/7533045/7716a2650038/10735_2020_9915_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac9/7533045/7716a2650038/10735_2020_9915_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac9/7533045/7716a2650038/10735_2020_9915_Fig1_HTML.jpg

相似文献

1
COVID-19 and multiorgan failure: A narrative review on potential mechanisms.COVID-19 与多器官衰竭:潜在机制的叙述性综述。
J Mol Histol. 2020 Dec;51(6):613-628. doi: 10.1007/s10735-020-09915-3. Epub 2020 Oct 4.
2
Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients.肺泡巨噬细胞功能障碍和细胞因子风暴在两例严重 COVID-19 患者发病机制中的作用。
EBioMedicine. 2020 Jul;57:102833. doi: 10.1016/j.ebiom.2020.102833. Epub 2020 Jun 20.
3
Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes.血管紧张素转化酶 2(ACE2):COVID-19 导致多器官衰竭综合征的门户。
Respir Physiol Neurobiol. 2021 Jan;283:103548. doi: 10.1016/j.resp.2020.103548. Epub 2020 Sep 18.
4
Organ-specific manifestations of COVID-19 infection.COVID-19 感染的器官特异性表现。
Clin Exp Med. 2020 Nov;20(4):493-506. doi: 10.1007/s10238-020-00648-x. Epub 2020 Jul 27.
5
ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome.ACE2 受体多态性:易感性、高血压、多器官衰竭与 COVID-19 疾病结局。
J Microbiol Immunol Infect. 2020 Jun;53(3):425-435. doi: 10.1016/j.jmii.2020.04.015. Epub 2020 May 6.
6
The Science Underlying COVID-19: Implications for the Cardiovascular System.新型冠状病毒肺炎相关科学:对心血管系统的影响。
Circulation. 2020 Jul 7;142(1):68-78. doi: 10.1161/CIRCULATIONAHA.120.047549. Epub 2020 Apr 15.
7
The Possible Dual Role of the ACE2 Receptor in Asthma and Coronavirus (SARS-CoV2) Infection.血管紧张素转换酶2(ACE2)受体在哮喘和冠状病毒(SARS-CoV2)感染中的潜在双重作用
Front Cell Infect Microbiol. 2020 Sep 23;10:550571. doi: 10.3389/fcimb.2020.550571. eCollection 2020.
8
Cytokine storm intervention in the early stages of COVID-19 pneumonia.COVID-19 肺炎早期的细胞因子风暴干预。
Cytokine Growth Factor Rev. 2020 Jun;53:38-42. doi: 10.1016/j.cytogfr.2020.04.002. Epub 2020 Apr 25.
9
The amount of cytokine-release defines different shades of Sars-Cov2 infection.细胞因子释放的程度定义了 SARS-CoV-2 感染的不同程度。
Exp Biol Med (Maywood). 2020 Jun;245(11):970-976. doi: 10.1177/1535370220928964. Epub 2020 May 28.
10
Is the kidney a target of SARS-CoV-2?肾脏是否是 SARS-CoV-2 的靶器官?
Am J Physiol Renal Physiol. 2020 Jun 1;318(6):F1454-F1462. doi: 10.1152/ajprenal.00160.2020. Epub 2020 May 15.

引用本文的文献

1
Isogenic induced-pluripotent-stem-cell-derived airway- and alveolus-on-chip models reveal specific innate immune responses.同基因诱导多能干细胞来源的芯片上气道和肺泡模型揭示了特定的先天免疫反应。
Nat Biomed Eng. 2025 Jul 16. doi: 10.1038/s41551-025-01444-2.
2
SARS-CoV-2 Infection Is Associated with an Accelerated eGFR Decline in Kidney Transplant Recipients up to Four Years Post Infection.严重急性呼吸综合征冠状病毒2感染与肾移植受者感染后长达四年的估算肾小球滤过率加速下降有关。
Diagnostics (Basel). 2025 Apr 25;15(9):1091. doi: 10.3390/diagnostics15091091.
3
Autophagy and Respiratory Viruses: Mechanisms, Viral Exploitation, and Therapeutic Insights.

本文引用的文献

1
Highly pathogenic coronavirus N protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation.高致病性冠状病毒 N 蛋白通过 MASP-2 介导的凝集素补体途径过度激活加重炎症。
Signal Transduct Target Ther. 2022 Sep 14;7(1):318. doi: 10.1038/s41392-022-01133-5.
2
Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection.人类肾脏是新型严重急性呼吸综合征冠状病毒 2 感染的靶器官。
Nat Commun. 2021 May 4;12(1):2506. doi: 10.1038/s41467-021-22781-1.
3
Hemostatic Abnormalities in COVID-19: An Update.
自噬与呼吸道病毒:机制、病毒利用及治疗见解
Cells. 2025 Mar 12;14(6):418. doi: 10.3390/cells14060418.
4
A Systematic Review of Case Reports of New-Onset Atrial Fibrillation in COVID-19 Patients.新型冠状病毒肺炎患者新发心房颤动病例报告的系统评价
Cureus. 2025 Feb 13;17(2):e78938. doi: 10.7759/cureus.78938. eCollection 2025 Feb.
5
Development and validation of a nomogram to assess the occurrence of liver dysfunction in patients with COVID-19 pneumonia in the ICU.一种用于评估ICU中新冠肺炎患者肝功能障碍发生情况的列线图的开发与验证
BMC Infect Dis. 2025 Mar 10;25(1):332. doi: 10.1186/s12879-025-10684-1.
6
Prevalence and Risk Factors for Acute Kidney Injury in COVID-19-Hospitalized Patients in Poland Across Three Pandemic Periods.波兰三个疫情时期新冠住院患者急性肾损伤的患病率及危险因素
J Clin Med. 2025 Feb 19;14(4):1384. doi: 10.3390/jcm14041384.
7
Challenging the notion of endothelial infection by SARS-CoV-2: insights from the current scientific evidence.挑战新冠病毒感染内皮细胞的观念:基于当前科学证据的见解
Front Immunol. 2025 Feb 4;16:1443932. doi: 10.3389/fimmu.2025.1443932. eCollection 2025.
8
Alterations in menstrual characteristics and associated factors in Chinese women post SARS-CoV-2 infection: a cross-sectional study.新冠病毒感染后中国女性月经特征及相关因素的改变:一项横断面研究
BMC Womens Health. 2025 Feb 18;25(1):69. doi: 10.1186/s12905-025-03592-8.
9
Effectiveness and safety profile of mesenchymal stem cell secretome as a treatment for severe cases of COVID-19: a randomized controlled trial.间充质干细胞分泌组治疗重症 COVID-19 的有效性和安全性:一项随机对照试验
F1000Res. 2022 Jul 25;11:143. doi: 10.12688/f1000research.75580.2. eCollection 2022.
10
Outcomes of adults hospitalized with COVID-19 at the University Teaching Hospital of Butare in Rwanda and validation of the Universal Vital Assessment (UVA) mortality risk score.卢旺达布塔雷大学教学医院收治的新冠肺炎成年患者的治疗结果及通用生命评估(UVA)死亡率风险评分的验证
PLOS Glob Public Health. 2024 Dec 9;4(12):e0003695. doi: 10.1371/journal.pgph.0003695. eCollection 2024.
2019冠状病毒病的止血异常:最新进展
Indian J Hematol Blood Transfus. 2020 Oct;36(4):616-626. doi: 10.1007/s12288-020-01328-2. Epub 2020 Aug 11.
4
Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study).卡那奴单抗治疗 SARS-CoV-2 相关心肌损伤伴炎症升高患者心脏和呼吸功能恶化的疗效(卡那奴单抗治疗 COVID-19 相关心肌损伤:三个 C 研究)。
Clin Cardiol. 2020 Oct;43(10):1055-1063. doi: 10.1002/clc.23451. Epub 2020 Aug 24.
5
Histopathological observations in COVID-19: a systematic review.新型冠状病毒肺炎的组织病理学观察:一项系统综述
J Clin Pathol. 2021 Feb;74(2):76-83. doi: 10.1136/jclinpath-2020-206995. Epub 2020 Aug 18.
6
Clinical Characteristics and Risk Factors of Cardiac Involvement in COVID-19.新型冠状病毒肺炎患者心脏受累的临床特征及危险因素。
J Am Heart Assoc. 2020 Sep 15;9(18):e016807. doi: 10.1161/JAHA.120.016807. Epub 2020 Aug 18.
7
Characteristics of peripheral blood differential counts in hospitalized patients with COVID-19.住院 COVID-19 患者外周血差异计数的特征。
Eur J Haematol. 2020 Dec;105(6):773-778. doi: 10.1111/ejh.13509. Epub 2020 Sep 20.
8
COVID-19 and the Kidneys: An Update.新型冠状病毒肺炎与肾脏:最新进展
Front Med (Lausanne). 2020 Jul 21;7:423. doi: 10.3389/fmed.2020.00423. eCollection 2020.
9
Advances in research on ACE2 as a receptor for 2019-nCoV.新型冠状病毒受体 ACE2 研究进展。
Cell Mol Life Sci. 2021 Jan;78(2):531-544. doi: 10.1007/s00018-020-03611-x. Epub 2020 Aug 11.
10
Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series.巨核细胞和血小板-纤维蛋白血栓是新冠病毒病尸检时多器官血栓形成的特征:病例系列
EClinicalMedicine. 2020 Jun 25;24:100434. doi: 10.1016/j.eclinm.2020.100434. eCollection 2020 Jul.